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o r i g i n a l a r t i c l e
Multicenter Study of the Impact of Community-Onset Clostridium
difficile Infection on Surveillance for C. difficile Infection
Erik R. Dubberke, MD, MSPH; Anne M. Butler, MS; Bala Hota, MD, MPH; Yosef M. Khan, MBBS, MPH;
Julie E. Mangino, MD; Jeanmarie Mayer, MD; Kyle J. Popovich, MD; Kurt B. Stevenson, MD, MPH;
Deborah S. Yokoe, MD, MPH; L. Clifford McDonald, MD; John Jernigan, MD, MS; Victoria J. Fraser, MD; Prevention
Epicenters Program from the Centers for Disease Control and Prevention
objective. To evaluate the impact of cases of community-onset, healthcare facility (HCF)–associated Clostridium difficile infection (CDI)
on the incidence and outbreak detection of CDI.
design. A retrospective multicenter cohort study.
setting. Five university-affiliated, acute care HCFs in the United States.
methods. We collected data (including results of C. difficile toxin assays of stool samples) on all of the adult patients admitted to the
5 hospitals during the period from July 1, 2000, through June 30, 2006. CDI cases were classified as HCF-onset if they were diagnosed
more than 48 hours after admission or as community-onset, HCF-associated if they were diagnosed within 48 hours after admission and
if the patient had recently been discharged from the HCF. Four surveillance definitions were compared: cases of HCF-onset CDI only
(hereafter referred to as HCF-onset CDI) and cases of HCF-onset and community-onset, HCF-associated CDI diagnosed within 30, 60,
and 90 days after the last discharge from the study hospital (hereafter referred to as 30-day, 60-day, and 90-day CDI, respectively). Monthly
CDI rates were compared. Control charts were used to identify potential CDI outbreaks.
results. The rate of 30-day CDI was significantly higher than the rate of HCF-onset CDI at 2 HCFs ( ). The rates of 30-day CDIP ! .01
were not statistically significantly different from the rates of 60-day or 90-day CDI at any HCF. The correlations between each HCF’s
monthly rates of HCF-onset CDI and 30-day CDI were almost perfect (r range, 0.94–0.99; ). Overall, 12 time points had a CDIP ! .001
rate that was more than 3 standard deviations above the mean, including 11 time points identified using the definition for HCF-onset
CDI and 9 time points identified using the definition for 30-day CDI, with discordant results at 4 time points ( ; ).kp 0.794 P ! .001
Conclusions. Tracking cases of both community-onset and HCF-onset, HCF-associated CDI captures significantly more CDI cases, but
surveillance of HCF-onset, HCF-associated CDI alone is sufficient to detect an outbreak.
Infect Control Hosp Epidemiol 2009; 30:518-525
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Clostridium difficile is the most common cause of infectious
diarrhea among hospitalized patients, causing significant
morbidity, mortality, and increase in healthcare costs.1,2 In-
patient stay in a healthcare facility (HCF) is a well-established
risk factor for both C. difficile colonization and C. difficile
infection (CDI).3,4 Although earlier studies suggest a relatively
short incubation period (ie, 3–7 days),4,5 patients often de-
velop CDI after discharge from an HCF.6-9 More recent evi-
dence indicates that CDI onset after discharge from an HCF
may be increasing.10 The majority of patients with CDI onset
after discharge from an HCF have symptom onset within 4
weeks of discharge,6,8 although CDI symptom onset may oc-
cur in patients as many as 2–3 months after discharge.7,9
Current surveillance definitions of CDI—which were de-
veloped to assess disease trends, detect outbreaks, and facil-
itate comparison of CDI rates among similar institutions—
incorporate previous HCF exposure information.10 However,
the decision of individual HCFs to report cases of commu-
nity-onset, HCF-associated CDI in addition to cases of HCF-
onset CDI is dependent on their ability to accurately and
efficiently collect HCF exposure information, categorize cases,
and report rates. Because of the limited infection prevention
surveillance definitions of cdi 519
table 1. Definitions of Healthcare Facility (HCF)–Associated Clostridium difficile Infection (CDI) According to Recent HCF Exposure
Type of CDI Definition
HCF-onset CDI Patient’s stool sample tested positive 148 h after admission to study hospital
30-day CDI Patient’s stool sample tested positive 148 h after admission to study hospital or tested positive X48 h
after admission to study hospital and X30 d after last study hospital discharge, with no other HCF
exposure prior to readmission
60-day CDI Patient’s stool sample tested positive 148 h after admission to study hospital or tested positive X48 h
after admission to study hospital and X60 d after last study hospital discharge, with no other HCF
exposure prior to readmission
90-day CDI Patient’s stool sample tested positive 148 h after admission to study hospital or tested positive X48 h
after admission to study hospital and X90 d after last study hospital discharge, with no other HCF
exposure prior to readmission
note. Cases of 30-day, 60-day, and 90-day CDI are cases of HCF-onset and community-onset, HCF-associated CDI diagnosed within 30, 60, and 90
days, respectively, after the last discharge from the study hospital.
and control resources, it is important to determine whether
tracking cases of community-onset, HCF-associated CDI im-
proves the ability of an HCF to detect an abnormal increase
in CDI rates. A recent study that was limited to medical wards
at a single institution reported that CDI rates that included
cases of community-onset, HCF-associated CDI closely reflect
CDI rates that include only cases of HCF-onset CDI.7 The
purpose of this study was to evaluate the impact of HCF
exposure on the incidence and outbreak detection of CDI at
5 geographically diverse hospitals in the United States.
methods
Our retrospective multicenter cohort study was conducted
by collecting data on all of the adult patients admitted to 5
university-affiliated, acute care medical facilities during the
period from July 1, 2000, through June 30, 2006. Eligibility
was limited to patients who were 18 years of age or older.
All 5 hospitals in our study participated in the Prevention
Epicenters Program of the Centers for Disease Control and
Prevention and are as follows: Barnes-Jewish Hospital (St.
Louis, MO), Brigham and Women’s Hospital (Boston, MA),
The Ohio State University Medical Center (Columbus, OH),
John H. Stroger Jr. Hospital (formerly known as Cook County
Hospital; Chicago, IL), and University of Utah Hospital (Salt
Lake City, UT). Data on the results of C. difficile toxin assays
of stool samples, number of patient-days, and dates of hos-
pital admission, hospital discharge, and assay testing were
collected from electronic databases. Toxin assay results from
1 hospital were not available for the period from July 1, 2000,
through June 30, 2001. Patients with CDI were defined as
any inpatient whose stool sample tested positive for C. difficile
by use of toxin assay. Chart review was performed for all
patients who had tested positive for C. difficile within 48 hours
after admission, to ascertain whether there was any HCF
exposure during the 90 days prior to hospital admission.
Recurrent cases of CDI—which were defined as a repeated
episode of CDI within 8 weeks of a previous episode of CDI—
were excluded from the analysis.10 Cases of community-onset,
community-associated CDI—which were defined as the onset
of symptoms within 48 hours after hospital admission and
no HCF exposure during the previous 90 days—and cases of
community-onset, HCF-associated CDI that were not attrib-
uted to a study hospital were also excluded.
Cases of CDI were classified as HCF-onset cases or com-
munity-onset, HCF-associated cases, according to a modified
version of published surveillance definitions.10 A patient with
HCF-onset CDI was defined as a patient whose stool sample
tested positive for C. difficile more than 48 hours after hospital
admission. A patient with community-onset, HCF-associated
CDI was defined as a patient whose stool sample tested pos-
itive for C. difficile within 48 hours after hospital admission,
provided that the diagnosis of CDI was received within 90
days after the last discharge from the study hospital and that
there was no other HCF exposure prior to readmission. To
evaluate the usefulness of incorporating recent HCF exposure
information into CDI surveillance definitions, 4 definitions
of HCF-associated CDI were compared: (1) HCF-onset CDI;
(2) HCF-onset and community-onset, HCF-associated CDI
diagnosed within 30 days after the last discharge from the
study hospital (hereafter referred to as 30-day CDI); (3) HCF-
onset and community-onset, HCF-associated CDI diagnosed
within 60 days after the last discharge from the study hospital
(hereafter referred to as 60-day CDI); and (4) HCF-onset and
community-onset, HCF-associated CDI diagnosed within 90
days after the last discharge from the study hospital (hereafter
referred to as 90-day CDI) (Table 1).
Data Analysis
For all 5 hospitals, monthly CDI rates (ie, cases per 10,000
patient-days) were calculated for each CDI definition. Cases
of HCF-onset CDI were attributed to the month of stool
collection for the C. difficile toxin assay, and cases of com-
munity-onset, HCF-associated CDI were attributed to the
month of discharge from the HCF before symptom onset.
Rates were compared with summary x2 tests with Bonferroni
correction (a P value of less than .01 was considered to be
statistically significant). Cross-correlation coefficients (r)
were calculated to assess the correlation in rate variability
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figure 1. Time to onset for cases of community-onset health-
care facility–associated Clostridium difficile infection (CDI) after
most recent discharge from 5 hospitals, from July 1, 2000, through
June 30, 2006.
table 2. Incidence Rates of Clostridium difficile Infection (CDI)
From July 1, 2000, Through June 30, 2006, Based on 4 Definitions
of Healthcare Facility (HCF)–Associated CDI
HCF









Hospital Aa 15.60 18.26 18.93 19.17
Hospital B 15.81 17.81 18.59 18.82
Hospital C 3.94 4.49 4.69 4.75
Hospital Db 6.23 7.05 7.27 7.33
Hospital Ea 4.49 5.39 5.62 5.72
Overalla,c 8.94 10.36 10.77 10.90
note. Cases of 30-day, 60-day, and 90-day CDI are cases of HCF-onset
and community-onset, HCF-associated CDI diagnosed within 30, 60, and
90 days, respectively, after the last discharge from the study hospital.
a The rate of HCF-onset CDI was significantly lower than that of 30-day
CDI ( ).P ! .01
b The study period was restricted to September 2001–March 2006.
c The overall rate of 30-day CDI was significantly lower than that of 90-day
CDI ( ).P ! 0.01
over time (in months) between CDI definitions. The annual
and overall hospital rankings by CDI rates were described.
These analyses excluded the last 3 months of the study period,
because we did not assess whether patients discharged in the
last 3 months of the study period presented to the study
hospital with CDI after the study period.
Statistical control charts were constructed for the surveil-
lance definitions of HCF-onset CDI and 30-day CDI, strat-
ified by hospital, to provide a standardized, objective method
to compare CDI rates by surveillance definition and to mon-
itor for the occurrence of abnormal increases in CDI rates.
Of primary interest was the comparison of the definition of
HCF-onset CDI with the definition of 30-day CDI, because
insignificant differences in CDI rates were found when we
compared the definition of 30-day CDI with the definition
of 60-day CDI and when we compared the definition of 60-
day CDI with the definition of 90-day CDI. This analysis
excluded the last month of the study period, because we did
not assess whether patients discharged in the last month of
the study period presented to the study hospital with C. dif-
ficile after the study period.
Shewhart u control charts were used, as described by Ben-
neyan11 and Sellick.12 Because of the discrete count data fol-
lowing a Poisson distribution with unequal size of monthly
patient-day subgroups, u control charts were the appropriate
choice of chart type. The primary indication for an abnormal
CDI rate was a value of more than 3 standard deviations
(SDs) from the mean.11 In addition, a supplementary set of
within-limit criteria, as described by Benneyan,13 was used to
identify nonrandom variation, such as trends, cycles, shifts
above the mean, and other forms of nonrandom or low-
probability behavior. For each hospital, incidence rates of
HCF-onset CDI and 30-day CDI were plotted. Time points
with abnormally high rates of CDI were identified by deter-
mining whether the monthly rate was more than 3 SDs above
the mean rate for the study period and by using the within-
limit criteria; abnormal time points that were defined by the
within-limit criteria were labeled at the first time point, to
meet the criteria. The k statistic was calculated to measure
the agreement between the number of times an abnormal
CDI rate was detected by use of the definitions of HCF-onset
CDI and 30-day CDI.
All tests were 2-tailed, and a P value of less than .05 was
considered to be statistically significant. Statistical analyses
were performed by use of SPSS for Windows, version 14.0
(SPSS). Approval for our study was obtained from the human
research protection offices of all 5 participating medical
centers.
results
During the 6-year study period, the participating hospitals
identified 4,668 cases of HCF-onset CDI and 1,027 cases of
community-onset, HCF-associated CDI with the most recent
discharge from the study hospital within 90 days. Of the 1,027
cases of community-onset, HCF-associated CDI, 744 (72%)
were diagnosed within 30 days after last hospital discharge,
211 (21%) were diagnosed within 31–60 days, and 72 (7%)
were diagnosed within 61–90 days (Figure 1).
The incidence rates of CDI that are based on the 4 defi-
nitions of HCF-associated CDI are presented in Table 2 and
are stratified by hospital. The overall HCF-onset CDI rate
was significantly lower than the 30-day CDI rate (8.94 vs
10.36 cases per 10,000 patient-days; ). There were noP ! .001
significant differences between the HCF-onset CDI rate and
the 30-day CDI rate at 3 hospitals (ie, hospitals B, C, and
D). Overall incidence rates of CDI were not statistically sig-
nificantly different between 30-day CDI and 60-day CDI
(10.36 vs 10.77 cases per 10,000 patient-days; ) orPp .05
between 60-day CDI and 90-day CDI (10.77 vs 10.90 cases
per 10,000 patient-days; ). Overall incidence ratesPp .50
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figure 2. Rates of Clostridium difficile infection (CDI) according to 2 surveillance definitions at hospitals A (top) and B (bottom). Solid
black circles, abnormally high incidence of healthcare facility (HCF)–onset CDI (which was determined by a monthly rate that was more
than 3 standard deviations [SDs] above the mean); open circles, abnormally high incidence of HCF-onset CDI (which was determined on
the basis of within-limit criteria); solid black triangles, abnormally high incidence of HCF-onset and community-onset, HCF-associated
CDI diagnosed within 30 days after the last discharge from the study hospital (30-day CDI; which was determined by a monthly rate was
more than 3 SDs above the mean); open triangles, abnormally high incidence of 30-day CDI (which was determined on the basis of within-
limit criteria).
were significantly lower for 30-day CDI than for 90-day CDI
(10.36 vs 10.90 cases per 10,000 patient-days; ) butP ! .01
not at any of the individual hospitals.
The rank order of hospitals by CDI rates remained constant
across all definitions within each study year. In addition, the
hospital rankings for the entire study period remained constant
across the different definitions: hospital B maintained the high-
est rate, followed by hospitals A, D, E, and C (Table 2).
The correlations between each hospital’s monthly rates of
HCF-onset CDI and 30-day CDI were almost perfect (r range,
0.94–0.99; ). There were similar correlations betweenP ! .001
the rate of 30-day CDI and the rate of 60-day CDI (r range,
0.98–1.00; ) and between the rate of 60-day CDIP X .001
and the rate of 90-day CDI ( for all; ).rp 1.00 P ! .05
Figures 2 and 3 present the incidence rates and the ab-
normal time points for the HCF-onset CDI and 30-day CDI
figure 3. Rates of Clostridium difficile infection (CDI) according to 2 surveillance definitions at hospitals C (top), D (middle), and E
(bottom). Solid black circles, abnormally high incidence of healthcare facility (HCF)–onset CDI (which was determined by a monthly rate
that was more than 3 standard deviations [SDs] above the mean); open circles, abnormally high incidence of HCF-onset CDI (which was
determined on the basis of within-limit criteria); solid black triangles, abnormally high incidence of HCF-onset and community-onset, HCF-
associated CDI diagnosed within 30 days after the last discharge from the study hospital (30-day CDI; which was determined by a monthly
rate was more than 3 SDs above the mean); open triangles, abnormally high incidence of 30-day CDI (which was determined on the basis
of within-limit criteria)
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table 3. Comparison of Abnormal Monthly Rates Identified by Use of 2 Surveillance Definitions of
Healthcare Facility (HCF)–Associated Clostridium difficile Infection (CDI) at 5 HCFs, July 1, 2000–June 30,
2006
HCF
No. of months with monthly rate
13 SDs above the center line
No. of months with monthly rate
13 SDs above the center line and
the within-limit criteriaa
HCF-onset CDI 30-day CDI kb HCF-onset CDI 30-day CDI kb
Hospital A 3 3 1.00 4 4 0.735
Hospital B 7 5 0.818 8 9 0.666
Hospital C 1 0 Not calculatedc 2 2 1.00
Hospital D 0 0 1.00 0 0 1.00
Hospital E 0 1 Not calculatedc 3 3 0.304
Total 11 9 0.794 17 18 0.669
note. Cases of 30-day CDI are cases of HCF-onset and community-onset, HCF-associated CDI diagnosed within 30
days after the last discharge from the study hospital.
a Supplementary within-limit criteria were considered in the absence of time points with abnormal rates during which
the monthly CDI rate was 13 standard deviations (SDs) above the center line.
b for all comparisons.P X .01
c The k statistic was not calculated because the values for either the HCF-onset CDI or 30-day CDI surveillance definition
were constant.
definitions, stratified by hospital. During the study period, 4
(80%) of the 5 hospitals detected at least 1 time point at
which the monthly CDI rate was more than 3 SDs above the
center line (Table 3), with a range of 1–7 abnormal time
points per hospital. Overall, 12 time points were identified
as having a monthly CDI rate that was more than 3 SDs
above the center line, including 11 time points identified
using the definition for HCF-onset CDI and 9 time points
identified using the definition for 30-day CDI, with discor-
dant results at 4 time points ( ; ). There waskp 0.794 P ! .001
perfect agreement between the HCF-onset CDI rate and the
30-day CDI rate at 2 hospitals (ie, hospitals A and D), with
a total of 3 time points at which the monthly CDI rate was
more than 3 SDs above the center line. There was almost
perfect agreement at 3 hospitals (ie, hospitals B, C, and E).
At hospital B, there were 7 months during which the monthly
CDI rates were more than 3 SDs above the center line: for
5 months, the rates were identified by use of both the defi-
nition for HCF-onset CDI and the definition for 30-day CDI,
and for 2 months, the rates were identified by use of the
definition for HCF-onset CDI only. At hospital C, there was
1 month during which the HCF-onset CDI rate was more
than 3 SDs above the center line, but no abnormally high
monthly CDI rates were identified using the definition for
30-day CDI. At hospital E, there was 1 month during which
the 30-day CDI rate was more than 3 SDs above the center
line, but no abnormally high monthly CDI rates were iden-
tified using the definition for HCF-onset CDI. In addition to
the 11 time points identified as having HCF-onset CDI rates
that were more than 3 SDs above the center line, the more
conservative supplementary within-limit criteria identified 5
more months with abnormally high HCF-onset CDI rates (1
month each at hospitals A, B, and C and 2 months at hospital
E). Similarly, the more conservative supplementary within-
limit criteria identified 8 more months with abnormally high
30-day CDI rates (1 month at hospitals A and C, 2 months
at hospital E, and 4 months at hospital B) in addition to the
9 time points identified as having 30-day CDI rates that were
more than 3 SDs above the center line. When combining the
results of abnormally high CDI rates that were detected either
on the basis of whether the monthly rate was more than 3
SDs above the center line or on the basis of the within-limit
criteria, the overall k statistic decreased to 0.669 ( )P ! .001
(Table 3).
discussion
To our knowledge, this is the first multicenter study to com-
pare standardized CDI surveillance definitions across insti-
tutions to determine the influence that these different defi-
nitions have on perceived CDI incidence and on the detection
of abnormal increases in CDI rates. The results of our in-
vestigation suggest that tracking cases of both community-
onset and HCF-onset, HCF-associated CDI captures signif-
icantly more cases of CDI but does not improve the ability
of HCFs to detect abnormally high rates of CDI. Compared
with the surveillance of only cases of HCF-onset CDI, the
expanded surveillance definitions that also track cases of com-
munity-onset, HCF-associated CDI had excellent correlation
over time and almost perfect agreement for detection of ab-
normally high CDI rates. The rank order of hospitals by CDI
rates did not vary by surveillance definition; instead, the hos-
pital rankings remained constant within each study year as
well as during the 6-year study period. From a public health
perspective, the primary purposes of CDI surveillance are to
guide the implementation of interventions to control CDI in
HCFs and to monitor the impact of such interventions.
Therefore, it is critical that surveillance definitions have the
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ability to accurately identify outbreaks. Our findings provide
evidence that surveillance of HCF-onset, HCF-associated CDI
alone is sufficient to detect an outbreak.
We found excellent correlation of rates over time between
the HCF-onset and the community-onset, HCF-associated
surveillance definitions, which reflects the high proportion of
CDI cases captured by the HCF-onset definition. In our study,
of the 5,695 cases of HCF-associated CDI, 4,668 (82%) were
cases of HCF-onset CDI. This proportion is consistent with
that from a study by Kutty et al.,8 who reported that 77% of
the cases of HCF-associated CDI that occurred within 90 days
after hospital discharge were cases of HCF-onset CDI. Al-
though uncertainty exists regarding the typical incubation
period from exposure to infection,4,5 the high proportion of
cases with HCF-onset CDI is not surprising, because inpatient
stay at an HCF is a major risk factor for the development of
C. difficile colonization or infection. Biological explanations
for the increased risk of CDI at an HCF include exposure to
concurrently admitted patients with CDI, antimicrobial use,
and the advanced age and severity of illness in patients at
HCFs.3,4,14
Current surveillance definitions classify cases of commu-
nity-onset, HCF-associated CDI on the basis of the timing
of recent HCF exposures. Published studies report that the
majority of patients who experience symptoms of CDI later
do so within 4 weeks after discharge from an HCF,6-8 although
there are some patients who experience symptoms as many
as 2–3 months after discharge.7,9 For instance, Kutty et al.8
identified 70% of the cases of community-onset, HCF-as-
sociated CDI within the first 30 days after hospital discharge,
and Chang et al.6 identified 85% of the cases of community-
onset, HCF-associated CDI within the first 30 days after hos-
pital discharge. Unlike our study, which focused exclusively
on hospital-based surveillance, these studies employed sur-
veillance strategies that captured cases managed in outpatient
settings. Because the availability of toxin assay results for
outpatients varies across HCFs, we focused exclusively on
hospital-based surveillance to increase the generalizability of
our findings. Despite different surveillance approaches, our
study identified 744 (72%) of the 1,027 cases of community-
onset, HCF-associated CDI within the first 30 days after hos-
pital discharge, an estimate that falls between the Kutty et
al.8 and Chang et al.6 estimates.
A unique strength of this study was the use of statistical
control charts to evaluate the influence of surveillance of
community-onset, HCF-associated CDI on outbreak detec-
tion. Use of the definitions for 60-day and 90-day CDI did
not result in significantly higher CDI rates at any of the
hospitals, compared with use of the definition for 30-day CDI.
In fact, the CDI rates that were reported using the definitions
for 60-day and 90-day CDI were approximately 100% con-
cordant with the CDI rates that were reported using the def-
inition for 30-day CDI; therefore, we focused the control chart
analysis on the definitions for HCF-onset CDI and 30-day
CDI. Despite the significantly higher 30-day CDI rates than
HCF-onset CDI rates at 2 of the 5 hospitals, use of the HCF-
onset CDI and 30-day CDI definitions resulted in the detec-
tion of similar totals of abnormally high time points using
the more than 3 SDs criteria with the addition of the more
conservative within-limit criteria. The k values for HCF-onset
CDI and 30-day CDI surveillance indicate substantial con-
cordance between the 2 definitions to identify abnormally
high CDI rates. Many of the discordant time points deter-
mined by 1 definition were different by only 1 month, com-
pared with the time points determined by the other definition.
The k value improved to 0.899 when the months with ab-
normally high HCF-onset CDI rates (which were determined
either on the basis of whether the monthly rate was more
than 3 SDs above the center line or on the basis of the within-
limit criteria) that occurred within 1 month of abnormally
high 30-day CDI rates, and vice versa, were considered to be
concordant. From a clinical perspective, the almost-perfect k
value calculated in the latter analysis provides evidence that
the simpler HCF-onset CDI surveillance definition accurately
identifies increases from endemic to epidemic CDI rates.
Statistical control charts provide a standardized, objective
method to monitor CDI rates but do not preclude the need
for visual inspection of CDI rates by infection prevention and
control practitioners. Despite the gradual increase in CDI
incidence during the study period at hospital E, an abnormal
time point based on a monthly rate that was more than 3
SDs above the center line was not identified until April 2006.
Other limitations of our study include a lack of generaliza-
bility to smaller, community hospitals. Because the academic
medical centers included in our study were large, there was
less variability in the rates of CDI, compared with the rates
in hospitals with lower patient-day totals and fewer cases of
CDI. This may explain the consistency in the rank order of
hospitals by annual CDI rates across our surveillance defi-
nitions as well as the excellent correlation between surveil-
lance definitions. In addition, the definitions of patient-days
varied slightly across study hospitals. However, the expected
impact on the results is minimal, because all comparisons
were intrahospital and used the same patient-day total for
the CDI rate denominator.
Although surveillance of HCF-onset, HCF-associated CDI
is currently considered to be the minimum surveillance re-
quired in healthcare settings,10 there is rationale for additional
tracking of cases of community-onset, HCF-associated CDI.
Currently, the transmission source for community-onset,
HCF-associated CDI is poorly understood. Past studies in-
dicate that patients with prior HCF exposures are more likely
to be colonized with C. difficile than are patients without
prior HCF exposures, which suggests acquisition from an
HCF.4,5 However, patients with community-onset, HCF-as-
sociated CDI frequently present to the hospital with symp-
toms of CDI more than 7 days after hospital discharge, which
is beyond the understood incubation period for CDI.4,5 Fur-
thermore, the strains of C. difficile present at hospital read-
mission may differ from the strains present at hospital dis-
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charge.5 The potential for acquisition of CDI after hospital
discharge has implications for HCFs, because this type of ac-
quisition may introduce new strains into the healthcare setting
and may be a source of CDI transmission, contributing to rates
of HCF-onset CDI.5 In addition, studies indicate that the risk
factors for community-onset, community-associated CDI may
differ from the risk factors for HCF-onset CDI.15,16 It is also
possible that the risk factors for community-onset, HCF-as-
sociated CDI may differ from the risk factors for HCF-onset
CDI.7 Therefore, HCFs may need to tailor CDI prevention
efforts to target the more prevalent types of CDI in their in-
stitution. Future studies are needed to provide insight into
recent increases in the incidence of both HCF-onset and com-
munity-onset CDI, as well as to identify the transmission source
and risk factors for community-onset CDI.
To our knowledge, this is the first study to compare dif-
ferent standardized CDI surveillance definitions across insti-
tutions to determine whether the definitions impact the per-
ceived burden of CDI or alter the ability to detect a CDI
outbreak. Our findings suggest that 30 days after hospital
discharge is a reasonable time frame for surveillance of CDI
to detect cases associated with an HCF, but that HCFs have
the ability to accurately detect abnormal increases in CDI
rates with a more simplistic HCF-onset, HCF-associated case
definition. Given limited infection control resources, these
findings could have important implications for surveillance
methods in HCFs.
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